Literature DB >> 16138436

Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin.

Daniel N Nan1, Marta Fernández-Ayala, Carmen García-Ibarbia, Mar Gutiérrez-Santiago, José L Hernández.   

Abstract

The administration of intravesical bacille Calmette-Guérin (BCG) in early stages of bladder cancer is usually a safe therapy. Side-effects of BCG immunotherapy can be of both local and systemic nature. We report the first case of Henoch-Schönlein purpura following intravesical administration of BCG.

Entities:  

Mesh：

Year:  2005        PMID： 16138436     DOI： 10.1080/00365540510035300

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  4 in total

Review 1.  Urological Manifestations of Henoch-Schonlein Purpura: A Review.

Authors:  Amanda Dalpiaz; Richard Schwamb; Yimei Miao; Jacquelyn Gonka; Wayne Walzter; Sardar A Khan
Journal:  Curr Urol       Date:  2015-07-10

Review 2.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

3.  Henoch Schönlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy.

Authors:  Hiroyuki Tsukada; Hiroshi Miyakawa
Journal:  Intern Med       Date:  2017-03-01       Impact factor: 1.271

4.  Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature.

Authors:  Nigel P Murray; Cynthia Fuentealba; Isidora Salazar; Aníbal Salazar; Marco Antonio Lopez; Simona Minzer
Journal:  Case Rep Hematol       Date:  2018-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.